12.11.2007 13:30:00
|
Ecolab Closes on Purchase of Microtek
Ecolab Inc. announced today that it has expanded its infection
prevention expertise in the healthcare industry with the purchase of
Microtek Medical Holdings Inc. (Nasdaq:MTMD). The Alpharetta,
Georgia-based manufacturer and marketer of infection control products
for healthcare and acute care facilities specializes in infection
barrier equipment drapes, patient drapes, fluid control products and
operating room cleanup systems. Microtek’s
2006 sales were $142 million.
Microtek shareholders voted in favor of the proposed sale of the company
to Ecolab. Ecolab will pay $6.30 per Microtek share for the
approximately 43.7 shares of Microtek common stock outstanding as of
November 9, 2007.
Commenting on the transaction, Ecolab’s
Chairman, President and Chief Executive Officer Douglas M. Baker, Jr.
stated, "Microtek represents a terrific addition to the Ecolab family,
and furthers our efforts to become a leader in providing comprehensive
solutions to significantly reduce infections and contamination in the
healthcare environment. By combining Microtek’s
excellent barrier product lines with our complementary strength in skin
care, disinfectants and central sterile, Ecolab is now the only company
that can offer system-wide solutions for healthcare facilities that help
improve operational efficiencies, reduce infections, and most
importantly, improve patient safety.”
According to the U.S. Centers for Disease Control and Prevention, more
than two million healthcare patients contract hospital-acquired
infections (HAIs) annually in North America alone. The cost to treat
these individuals is estimated to be $30 billion to $50 billion
annually, and even with treatment, approximately 100,000 are believed to
die each year. With the Centers for Medicare and Medicaid Services
recently announcing they are considering excluding funding for "preventable”
HAIs, healthcare leaders are looking for help in solving this complex
problem more than ever before.
"Ecolab can provide the layers of protection
healthcare facilities are looking for,” Baker
added. "Our clinically trained healthcare
experts can offer healthcare facilities the latest in innovative
products and technologies; integrated clinical and support services;
data utilization and process improvement; training and continuing
education; quality assurance testing; thought leadership; and best
practices. We can help our customers clean the patient, break the
vectors that could contaminate the patient, and clean the healthcare
facility environment.”
With sales of $5 billion and more than 13,000 sales-and-service
associates, Ecolab Inc. (NYSE:ECL) is the global leader in cleaning,
sanitizing, food safety and infection prevention products and services.
Ecolab delivers comprehensive programs and services to foodservice, food
and beverage processing, healthcare, and hospitality markets in more
than 160 countries. More news and information is available at www.ecolab.com.
(ECL-A)
Der finanzen.at Ratgeber für Aktien!
Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
JETZT DEVISEN-CFDS MIT BIS ZU HEBEL 30 HANDELN
Handeln Sie Devisen-CFDs mit kleinen Spreads. Mit nur 100 € können Sie mit der Wirkung von 3.000 Euro Kapital handeln.
82% der Kleinanlegerkonten verlieren Geld beim CFD-Handel mit diesem Anbieter. Sie sollten überlegen, ob Sie es sich leisten können, das hohe Risiko einzugehen, Ihr Geld zu verlieren.
Nachrichten zu Ecolab Inc.mehr Nachrichten
26.11.24 |
S&P 500-Papier Ecolab-Aktie: So viel hätte eine Investition in Ecolab von vor 5 Jahren abgeworfen (finanzen.at) | |
19.11.24 |
S&P 500-Titel Ecolab-Aktie: So viel hätten Anleger an einem Ecolab-Investment von vor 3 Jahren verdient (finanzen.at) | |
12.11.24 |
S&P 500-Wert Ecolab-Aktie: So viel hätte eine Investition in Ecolab von vor einem Jahr abgeworfen (finanzen.at) | |
05.11.24 |
S&P 500-Papier Ecolab-Aktie: So viel Gewinn hätte ein Ecolab-Investment von vor 10 Jahren eingefahren (finanzen.at) | |
29.10.24 |
S&P 500-Titel Ecolab-Aktie: So viel Gewinn hätte eine Ecolab-Investition von vor 5 Jahren eingebracht (finanzen.at) | |
22.10.24 |
S&P 500-Titel Ecolab-Aktie: So viel Gewinn hätte eine Ecolab-Investition von vor 3 Jahren eingebracht (finanzen.at) | |
15.10.24 |
S&P 500-Titel Ecolab-Aktie: So viel Gewinn hätte eine Ecolab-Investition von vor einem Jahr eingebracht (finanzen.at) | |
14.10.24 |
Erste Schätzungen: Ecolab stellt Zahlen zum jüngsten Quartal vor (finanzen.net) |
Analysen zu Ecolab Inc.mehr Analysen
Aktien in diesem Artikel
Ecolab Inc. | 235,00 | 0,47% |
Indizes in diesem Artikel
S&P 500 | 6 047,15 | 0,24% |